Samantha Amanda Sathyapala – Behavioural Networks- Best Researcher Award

Posted on by usudeeparya

Samantha Amanda Sathyapala – Behavioural Networks – Best Researcher Award

Dr. S.A. Sathyapala distinguished academic and researcher in the field Behavioural Networks. Amanda Sathyapala is a Senior Lecturer in the Airways Disease Section of the National Heart and Lung Institute of Imperial College London and a Consultant Respiratory Physician, and Clinical Lead of the Home Ventilation Service, at Harefield Hospital. Her clinical expertise is in sleep-disordered breathing, which includes obstructive sleep apnoea (OSA) and hypoventilation secondary to obesity and severe chronic lung disease, chest wall deformity or neuromuscular conditions, chronic respiratory failure and home nocturnal non-invasive ventilation. She is also accredited to deliver Cognitive Behavioural Therapy for Insomnia. Her current research is aimed at improving patient adherence to CPAP. She is Research Committee Lead for the British Sleep Society and sits on their Executive Board, is a member of the Regional Advisory Committee (RAC) for the RfPB London region NIHR funding scheme and reviews for the top ranked respiratory and muscle journals.

🌐 Professional Profiles

Educations📚📚📚

Dr Sathyapala is a tenured academic at Imperial College London and a practising respiratory physician, specialising in Sleep Medicine at Guy’s and St Thomas’s NHS Foundation Trust in London, in the UK. She qualified with First Class Honours in Pre-Clinical Medicine and an intercalated BSc in Experimental Psychology at Cambridge University and completed her Clinical Medicine training at Oxford University (1996-1999). She completed her junior doctor training in Oxford and London and her PhD at the Royal Brompton Hospital in London and Maastricht University, which was funded by aprestigious Wellcome Trust Clinical Research Training Fellowship. She then took up her permanent position at Imperial College London after winning one of 30 national awards in the final roundof a scheme to support clinical academics long-term.

Research Experience

Her early work from PhD until late 2018 was on Chronic Obstructive Pulmonary Disease (COPD). In the last five years,Dr Sathypala’s focus has been on improving patient adherence to Continuous Positive Airway Pressure (CPAP) in patients with obstructive sleep apnea (OSA). Her grouphave identified that there are six early patterns of behaviour inpatient starting CPAP and that these strongly predict adherence to CPAP at Month 3 of treatment which in turn strongly predicts long-term adherence.These refute previous thinking and will result in current recommendations for practicebeing changed.

🏆🏆Awards🏆🏆

She was awarded a Wellcome Trust Clinical Research Training Fellowship to complete her PhD (awarded 2011) in Professor Mike Polkey’s lab at the Royal Brompton Hospital, which also included a year abroad in the Netherlands, at Maastricht University in Professor Annemie Schols’ lab. Dr Sathyapala was awarded a HEFCE Clinical Senior Lectureship; since 2012, she has been a Senior Lecturer and a Principal Investigator at the NHLI and an Consultant Physician at the Royal Brompton and Harefield NHS Foundation Trust. She was elected as Fellow to the Royal College of Physicians in April 2015.

 

Research interests

Dr Sathyapala’s research relates to adherence to CPAP in patients with OSA which is low based on existing data from trial participants. Her group have demonstrated that CPAP adherence rates are very low in clinical cohorts across the UK, between 27-50% in 2019 and 29-51% in 2020 and described a novel model of CPAP adherence behaviour. Her team are current developing a healthcare intervention for NHS sleep services to provide patients when starting CPAP to increase patients’ adherence to CPAP.

PREVIOUS RESEARCH

Dr Sathyapala’s work has previously been on skeletal muscle dysfunction in COPD and in other chronic diseases, in particular to identify molecular mechanisms which underlie premature muscle fatigue hence exercise intolerance and which are amenable to drug treatment. This is a small field but one of growing importance as skeletal muscle dysfunction is an important cause of frailty, which is a growing problem in ageing populations. To raise awareness of importance of this problem and to foster collaborative working between basic and clinical scientists with common interests, Dr Sathyapala hosted the first international symposium on ‘Skeletal muscle oxidative metabolism as a target for treating human disease’ at the NHLI in 2016.

📝🔬Publications📝🔬

 

Chun Cao | Network Science

Posted on by usudeeparya
  Dr.  Chun Cao – Network Science

Academician/Research Scholar

Congratulations,Dr.  Chun Cao – Network Science , on winning the esteemed Best Researcher Award from Sfconference! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Wishing you continued success and many more milestones in your illustrious research journey. Your impact on the field is truly commendable and serves as a beacon of inspiration for aspiring researchers.

Warmest congratulations once again on this well-deserved recognition!

 

Professional Profiles:

Education:

    • Doctor degree of medicine in West China Clinical Medical School of Sichuan univeresity.
    • Major; Hematology (Stem cell transplantation)
    • Bechelor and Master degree of Medicine in West china Clinical Medical School of sichuan University.

Awards:

1.The second prize for Medical bilingual lecture contest in the second affiliated Hospital of chongqing Medical university.

2.The best teaching plan award for Medical bilingual lecture contest in the second affiliated Hospital of chongqing Medical university.

publication;

1. Cao C, Wang T, Luo Y, Zhang Y, Dai YY, Shen Y. Comprehensive analysis of cuproptosis-associated LncRNAs predictive value and related CeRNA network in acute myeloid leukemia. Heliyon. 2023;9(12):e22532. Published 2023 Nov 25. doi:10.1016/j.heliyon.2023.e22532
2. Cao C, Zhang L, Sorensen MD, et al. D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function [published correction appears in J Neuropathol Exp Neurol. 2023 Nov 07;:]. J Neuropathol Exp Neurol.
2023;82(11):921-933. doi:10.1093/jnen/nlad0723. Cao C, Li X, Liu T, Zhang L, Shen K, Zhu H. Human organic cation transporter 1 protein levels of granulocytes can optimize imatinib therapy in patients with chronic myeloid leukemia. Acta Haematol. 2015;133(2):199-204. doi:10.1159/0003654374. Cao C, Liu T, Zhu H, Wang L, Kai S, Xiang B. Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review. Clin Lymphoma Myeloma Leuk. 2014;14(5):e145-e150. doi:10.1016/j.clml.2014.03.002
5. Cao C, Liu S, Lou SF, Liu T. The +252A/G polymorphism in the Lymphotoxin-α gene and the risk of non-Hodgkin lymphoma: a meta-analysis. Eur Rev Med Pharmacol Sci. 2014;18(4):544-552.
6.Cao C, Liu T, Lou S, Liu W, Shen K, Xiang B. Unusual presentation of duodenal plasmablastic lymphoma in an immunocompetent patient: A case report and literature review. Oncol Lett. 2014;8(6):2539-2542. doi:10.3892/ol.2014.26047.Sun Y, Wei C, Cao C, et al. New Strategy of Acute Graft-vs-Host Disease: Investigation of a Reduced Dose of Antithymocyte Globulin in Haploidentical Hematopoietic Stem Cell Transplantation. Transplant Proc. 2019;51(3):890-895. doi:10.1016/
j.transproceed.2018.10.028

Fan Xu | Network Science

Posted on by usudeeparya
 Prof Dr.  Fan Xu | Network Science

Academician/Research Scholar

Congratulations, Prof Dr.  Fan Xu | Network Science , on winning the esteemed Best Researcher Award from Sfconference! Your dedication, innovative research, and scholarly contributions have truly made a significant impact in your field. Your commitment to advancing knowledge and pushing the boundaries of research is commendable. Here’s to your continued success in shaping the future of academia and making invaluable contributions to your field. Well done!

Wishing you continued success and many more milestones in your illustrious research journey. Your impact on the field is truly commendable and serves as a beacon of inspiration for aspiring researchers.

Warmest congratulations once again on this well-deserved recognition!

 

Professional Profiles:

Education:

  • Bachelor’s Degree (B.S):
    • Major: Pharmacology
    • Institution: Chengdu Medical College
    • Duration: 2003-2007
  • Master’s Degree (M.D):
    • Major: Biochemistry and Molecular Biology
    • Institution: Chongqing Medical University
    • Duration: 2009-2012
  • Doctoral Degree (Ph.D):
    • Major: System Biology
    • Institution: Chongqing Medical University
    • Duration: 2012-2015
  • Visiting Scholar:
    • Institution: Peking University Medical School (Beijing, China)
    • Duration: 2019-2020
    • Certificate Number: 2020059

Teaching Certification:

  • Teaching Certification (China):
    • Certificate Number: 20195100171005018
    • Qualified as a senior faculty member at higher education institutions.

Honors and Certificates:

  • Certificates from Sichuan Province:
    1. Certificate of Overseas Study (川留​​F397 号)
    2. Certificate of High-level Overseas Talents (川留​​F311 号)
  • Other Honors:
    1. Various awards and recognitions for scientific research, teaching, and innovation from Chengdu Medical College.
    2. Outstanding contributions and awards from external organizations and employers.

Research Interests:

  1. Behavioral Genetics and Cognitive Sciences
  2. Systems Biology and Integration of Omics Data
  3. Advanced Analysis of Medical Imaging

Author Information:

  • ResearcherID: HLW-1600-2023

Published Papers (Selected): Note: List includes some papers from 2022 and 2023.

  1. Correlation analysis between EEG data and facial expressions and sleep behaviors (2023)
  2. Accuracy of Raman spectroscopy in the diagnosis of Alzheimer’s disease (2023)
  3. Serum uric acid to serum creatinine ratio predicts neurological deterioration in branch atheromatous disease (2023)
  4. Endothelial function and arterial stiffness indexes in subjects with carotid plaque (2023)
  5. Landmarks in pancreatic cancer studies (2022)
  6. Vigilant Attention, Cerebral Blood Flow, and Grey Matter Volume Change after Acute Sleep Deprivation (2022)
  7. Depression symptoms and quality of life in empty-nest elderly (2022)
  8. Carotid plaque components and other carotid artery features associated with the risk of stroke (2022)
  9. Facial muscle movements in patients with Parkinson’s disease undergoing phonation tests (2022)
  10. A systematic review and meta-analysis comparing the ability of diagnostic of the third heart sound and left ventricular ejection fraction in heart failure (2022)